Latest news with #TheLongWalktoPutrajaya
The Sun
04-05-2025
- Health
- The Sun
Doctors not against mandatory price display, object to use under Act 723
PETALING JAYA: Doctors are not against price transparency for medicines but object to the enforcement of the recent mandatory price labelling move under the Price Control and Anti-Profiteering Act 2011 (Act 723), the Malaysian Medical Association (MMA) said in a statement today. Ahead of the planned march from the Health Ministry to the Prime Minister's Office (PMO) on Tuesday, titled 'Doctors Betrayed: The Long Walk to Putrajaya, MMA's Private Practitioners Section (PPS) chairman Datuk Dr Parmjit Singh Kuldip Singh said the symbolic walk aims to express the medical fraternity's deep disappointment over the application of Act 723 — a law not originally intended for the medical profession. The march would highlight concerns about the various unanswered questions on the medicine price display and the unresolved issue of stagnant private general practitioner consultation fees, a longstanding issue since 1992. 'We wish to reiterate that doctors are not against price transparency but strongly oppose Act 723 being used in the medical profession,' he said in a statement. Dr Parmjit said the march would go ahead as planned if there are no objections, as MMA have submitted all necessary documents to inform the relevant authorities about the gathering. He said a memorandum will be handed over to the PMO through a joint effort between the association and other doctors' associations during the march. Last week, Health Minister Datuk Seri Dr Dzulkefly Ahmad and Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali announced that the mandatory price labelling would take effect on May 1. In a joint statement, they said the move aims to ensure the public can make informed choices by knowing, comparing, and selecting the best prices when managing their medication expenses. 'This initiative is being introduced in line with the Madani Government's commitment to promoting price transparency through the Medicine Price Transparency Mechanism (MKHU). 'It will be enforced under the Price Control and Anti-Profiteering (Price Marking for Medicines) Order 2025, pursuant to the Price Control and Anti-Profiteering Act 2011 (Act 723),' they said. The price labelling requirement applies to all medicines for human use, including prescription and non-prescription drugs, over-the-counter (OTC) medicines, traditional remedies, health supplements, and extemporaneous preparations. It covers all private healthcare facilities and community pharmacies regulated under the Private Healthcare Facilities and Services Act 1998 [Act 586] that sell, supply, or administer medicines. Following this, MMA called for the suspension of the policy's rollout to ensure that the association's concerns were adequately discussed and resolved.
The Sun
04-05-2025
- Health
- The Sun
Doctors not against mandatory price display
PETALING JAYA: Doctors are not against price transparency for medicines but object to the enforcement of the recent mandatory price labelling move under the Price Control and Anti-Profiteering Act 2011 (Act 723), the Malaysian Medical Association (MMA) said in a statement today. Ahead of the planned march from the Health Ministry to the Prime Minister's Office (PMO) on Tuesday, titled 'Doctors Betrayed: The Long Walk to Putrajaya, MMA's Private Practitioners Section (PPS) chairman Datuk Dr Parmjit Singh Kuldip Singh said the symbolic walk aims to express the medical fraternity's deep disappointment over the application of Act 723 — a law not originally intended for the medical profession. The march would highlight concerns about the various unanswered questions on the medicine price display and the unresolved issue of stagnant private general practitioner consultation fees, a longstanding issue since 1992. 'We wish to reiterate that doctors are not against price transparency but strongly oppose Act 723 being used in the medical profession,' he said in a statement. Dr Parmjit said the march would go ahead as planned if there are no objections, as MMA have submitted all necessary documents to inform the relevant authorities about the gathering. He said a memorandum will be handed over to the PMO through a joint effort between the association and other doctors' associations during the march. Last week, Health Minister Datuk Seri Dr Dzulkefly Ahmad and Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali announced that the mandatory price labelling would take effect on May 1. In a joint statement, they said the move aims to ensure the public can make informed choices by knowing, comparing, and selecting the best prices when managing their medication expenses. 'This initiative is being introduced in line with the Madani Government's commitment to promoting price transparency through the Medicine Price Transparency Mechanism (MKHU). 'It will be enforced under the Price Control and Anti-Profiteering (Price Marking for Medicines) Order 2025, pursuant to the Price Control and Anti-Profiteering Act 2011 (Act 723),' they said. The price labelling requirement applies to all medicines for human use, including prescription and non-prescription drugs, over-the-counter (OTC) medicines, traditional remedies, health supplements, and extemporaneous preparations. It covers all private healthcare facilities and community pharmacies regulated under the Private Healthcare Facilities and Services Act 1998 [Act 586] that sell, supply, or administer medicines. Following this, MMA called for the suspension of the policy's rollout to ensure that the association's concerns were adequately discussed and resolved.
The Sun
04-05-2025
- Health
- The Sun
MMA objects to mandatory medicine price labelling, plans march to PMO
PETALING JAYA: Doctors are not against price transparency for medicines but object to the enforcement of the recent mandatory price labelling move under the Price Control and Anti-Profiteering Act 2011 (Act 723), the Malaysian Medical Association (MMA) said in a statement today. Ahead of the planned march from the Health Ministry to the Prime Minister's Office (PMO) on Tuesday, titled 'Doctors Betrayed: The Long Walk to Putrajaya, MMA's Private Practitioners Section (PPS) chairman Datuk Dr Parmjit Singh Kuldip Singh said the symbolic walk aims to express the medical fraternity's deep disappointment over the application of Act 723 — a law not originally intended for the medical profession. The march would highlight concerns about the various unanswered questions on the medicine price display and the unresolved issue of stagnant private general practitioner consultation fees, a longstanding issue since 1992. 'We wish to reiterate that doctors are not against price transparency but strongly oppose Act 723 being used in the medical profession,' he said in a statement. Dr Parmjit said the march would go ahead as planned if there are no objections, as MMA have submitted all necessary documents to inform the relevant authorities about the gathering. He said a memorandum will be handed over to the PMO through a joint effort between the association and other doctors' associations during the march. Last week, Health Minister Datuk Seri Dr Dzulkefly Ahmad and Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali announced that the mandatory price labelling would take effect on May 1. In a joint statement, they said the move aims to ensure the public can make informed choices by knowing, comparing, and selecting the best prices when managing their medication expenses. 'This initiative is being introduced in line with the Madani Government's commitment to promoting price transparency through the Medicine Price Transparency Mechanism (MKHU). 'It will be enforced under the Price Control and Anti-Profiteering (Price Marking for Medicines) Order 2025, pursuant to the Price Control and Anti-Profiteering Act 2011 (Act 723),' they said. The price labelling requirement applies to all medicines for human use, including prescription and non-prescription drugs, over-the-counter (OTC) medicines, traditional remedies, health supplements, and extemporaneous preparations. It covers all private healthcare facilities and community pharmacies regulated under the Private Healthcare Facilities and Services Act 1998 [Act 586] that sell, supply, or administer medicines. Following this, MMA called for the suspension of the policy's rollout to ensure that the association's concerns were adequately discussed and resolved.
The Sun
04-05-2025
- Health
- The Sun
MMA objects to mandatory medicine price labelling
PETALING JAYA: Doctors are not against price transparency for medicines but object to the enforcement of the recent mandatory price labelling move under the Price Control and Anti-Profiteering Act 2011 (Act 723), the Malaysian Medical Association (MMA) said in a statement today. Ahead of the planned march from the Health Ministry to the Prime Minister's Office (PMO) on Tuesday, titled 'Doctors Betrayed: The Long Walk to Putrajaya, MMA's Private Practitioners Section (PPS) chairman Datuk Dr Parmjit Singh Kuldip Singh said the symbolic walk aims to express the medical fraternity's deep disappointment over the application of Act 723 — a law not originally intended for the medical profession. The march would highlight concerns about the various unanswered questions on the medicine price display and the unresolved issue of stagnant private general practitioner consultation fees, a longstanding issue since 1992. 'We wish to reiterate that doctors are not against price transparency but strongly oppose Act 723 being used in the medical profession,' he said in a statement. Dr Parmjit said the march would go ahead as planned if there are no objections, as MMA have submitted all necessary documents to inform the relevant authorities about the gathering. He said a memorandum will be handed over to the PMO through a joint effort between the association and other doctors' associations during the march. Last week, Health Minister Datuk Seri Dr Dzulkefly Ahmad and Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali announced that the mandatory price labelling would take effect on May 1. In a joint statement, they said the move aims to ensure the public can make informed choices by knowing, comparing, and selecting the best prices when managing their medication expenses. 'This initiative is being introduced in line with the Madani Government's commitment to promoting price transparency through the Medicine Price Transparency Mechanism (MKHU). 'It will be enforced under the Price Control and Anti-Profiteering (Price Marking for Medicines) Order 2025, pursuant to the Price Control and Anti-Profiteering Act 2011 (Act 723),' they said. The price labelling requirement applies to all medicines for human use, including prescription and non-prescription drugs, over-the-counter (OTC) medicines, traditional remedies, health supplements, and extemporaneous preparations. It covers all private healthcare facilities and community pharmacies regulated under the Private Healthcare Facilities and Services Act 1998 [Act 586] that sell, supply, or administer medicines. Following this, MMA called for the suspension of the policy's rollout to ensure that the association's concerns were adequately discussed and resolved.
Malay Mail
01-05-2025
- Health
- Malay Mail
Claiming ‘betrayal', doctors plan May 6 Putrajaya march against drug pricing law they say raises costs
KUALA LUMPUR, May 1 — The Malaysian Medical Association (MMA) will hold a protest march from the Health Ministry to the Prime Minister's Office in Putrajaya next Tuesday. The protest, called 'Doctors Betrayed: The Long Walk to Putrajaya', is aimed at opposing a new law that requires private healthcare facilities to display the prices of medicines, which takes effect today. 'We demand consultation. We demand justice. Join the march. Make your voice heard,' the MMA said in a poster on X. 'We demand consultation. We demand justice. @anwaribrahim — hear us,' the association added, tagging Prime Minister Datuk Seri Anwar Ibrahim. Private healthcare providers have criticised the new rule, saying it will increase operational costs and add administrative burdens. The new Price Control and Anti-Profiteering (Price Marking for Drugs) order, gazetted under the Price Control and Anti-Profiteering Act and signed by Domestic Trade and Cost of Living Minister Datuk Armizan Ali, requires private healthcare providers to display drug prices clearly to patients. Individual healthcare providers who fail to comply face a fine of up to RM50,000, while companies can be fined up to RM100,000. Under the order, drugs that are visible to customers must have price tags or labels attached. For medicines stored behind the counter or not visible to customers, a detailed price list must be made available. The price list must include the drug's generic name or active ingredient, strength, trade name, and price per unit, weight, or measure. It must also be displayed using physical or electronic means and be clearly visible and accessible to consumers.
